Back to KERX Stock Lookup

KERX – Press Releases

Apr 15, 2014 08:30 AM Keryx Biopharmaceuticals Strengthens Leadership Team With Key Additions in Sales, Corporate Development and Legal
Apr 9, 2014 08:30 AM Keryx Biopharmaceuticals Announces Zerenex(TM) (Ferric Citrate Coordination Complex) Phase 2 Results in Non-Dialysis Dependent Chronic Kidney Disease Selected as a Late Breaking Oral Presentation at t
Apr 2, 2014 08:30 AM Keryx Biopharmaceuticals Announces EMA Validation of Marketing Authorization Application for Zerenex(TM)
Apr 1, 2014 08:00 AM Foresite Capital Closes $300 Million Fund II to Finance Late-Stage Healthcare Companies
Mar 17, 2014 08:30 AM Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo
Mar 17, 2014 08:30 AM Keryx Biopharmaceuticals' Zerenex(TM) Data Selected for Poster Presentation at the AMCP's 26th Annual Meeting and Expo
Mar 12, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results
Mar 12, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. Announces Fourth Quarter and Year-End 2013 Financial Results
Mar 11, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2013 Financial Results
Mar 11, 2014 04:30 PM Keryx Biopharmaceuticals, Inc. to Host Conference Call on Fourth Quarter and Year End 2013 Financial Results
Mar 10, 2014 08:30 AM Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency
Mar 10, 2014 08:30 AM Keryx Biopharmaceuticals Announces Submission of a Marketing Authorization Application for Zerenex(TM) to the European Medicines Agency
Feb 26, 2014 08:30 AM Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
Feb 26, 2014 08:30 AM Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences
Feb 18, 2014 08:30 AM Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing
Feb 18, 2014 08:30 AM Keryx Biopharmaceuticals Announces the Appointment of Abraham Ceesay as Vice President of Marketing
Feb 10, 2014 08:30 AM Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer
Feb 10, 2014 08:30 AM Keryx Biopharmaceuticals Appoints Greg Madison as Chief Operating Officer
Feb 6, 2014 08:30 AM Keryx Biopharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference
Feb 6, 2014 08:30 AM Keryx Biopharmaceuticals to Present at the 16th Annual BIO CEO & Investor Conference
Jan 22, 2014 07:42 PM Keryx Biopharmaceuticals Announces Pricing of Public Offering of Common Stock
Jan 21, 2014 04:19 PM Keryx Biopharmaceuticals, Inc. Announces $90 Million Proposed Public Offering of Common Stock
Jan 21, 2014 08:30 AM Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Jan 21, 2014 08:30 AM Keryx Biopharmaceuticals Announces Appointment of Daniel W. Olmstead as Vice President, Payer Access
Jan 7, 2014 08:30 AM Keryx Biopharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference
Dec 18, 2013 08:30 AM Keryx Biopharmaceuticals Announces Issuance of U.S. Patent for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate
Dec 9, 2013 08:30 AM Keryx Biopharmaceuticals to Present at the 24th Annual Oppenheimer Healthcare Conference

Back to KERX Stock Lookup